Skip to content ↓

Here & There

INNOVATORS INTERVIEWED

Associate Professor Neil Gershenfeld, who heads the Media Lab's "Things That Think" consortium, and visiting scholar Michael Lynch (SB 1976, SM), who directs the Working Group on Asian Energy and Security in the Center for International Studies, are two of the subjects of video interviews incldued in Business Week Online's "100 Years of Innovation" issue. The archived interviews can be downloaded from the web site and viewed with RealPlayer.

IN THE WRITE

Robin Lippincott, a senior secretary in the Department of Materials Science and Engineering, has had his second book published. Mr. Dalloway (Sarabande), his first novel, is "a creative response" to the Virginia Woolf classic of similar title, he says. It focuses on one day in the life of former Parliament member Richard Dalloway, his family and the affair that threatens it.

"By using recognizably Woolfian techniques -- shifting points of view, extensive inner monologue -- the author pays homage to Woolf while at the same time creating his own vision of a straitjacketed, homophobic England," wrote Publisher's Weekly on June 14. "This is imitation in its finest form, as one writer draws from another to create a convincing world."

Mr. Lippincott is also author of The Real, True Angel (Fleur-de-Lis Press, 1996), a book of short stories.

A version of this article appeared in MIT Tech Talk on September 25, 1999.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story